Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 29 November 2024
Revised: 22 January 2025
Accepted: 26 January 2025
First Online: 7 February 2025
Declarations
:
: Approval from the Institutional Review Board was obtained, and in keeping with the policies for a retrospective review, informed consent was not required.
: Janeth Yinh is a consultant to Janssen, BICMD, and receives royalties from Springer Nature.Ali Guermazi is a consultant to Novartis, TissueGene, Coval, Medipost, 4Moving, Paradigm, Scarcell, Peptinov, Levicept, Pacira, ICM, and Formation Bio. He is a shareholder of BICL, LLC.Mohamed Jarraya has no relevant conflict of interest.
